French participants
- Centre européen d’étude du Diabète, Strasbourg. CeeD coordinated the consortium and contributed research on islet function.
- Defymed. The device developer brought expertise in prototype design, preclinical evaluation and planning for further development.
- Centre hospitalier universitaire de Montpellier. The university hospital supplied clinical and endocrinology expertise and helped frame the safety questions for future evaluation.
- Endocells. The archived site uses this name for the team that CORDIS identifies as Univercell-Biosolutions. It contributed work on alternative sources of insulin-producing cells.
United Kingdom participants
- AvantiCell Science, Scotland. The company brought cell culture and formulation expertise.
- University of Oxford. The Nuffield Department of Surgical Sciences brought experience with islet isolation and transplantation research.
Belgian participant
The laboratory of experimental surgery at the Catholic University of Louvain contributed expertise in evaluating the device in preclinical models.
Read how responsibilities were assigned in the project management structure.